Fibroblast activation protein (FAP)-targeted radioligand therapy has generated enormous excitement, but the first generation of agents has largely
Will Morton is a journalist at AuntMinnie.com. He covers a range of topics within medicine and healthcare, with a focus on digital x-ray and molecular imaging, as well as themes such as healthcare technology, diagnostics, and alternative medicine. Will's work has been featured in NewsBreak, Cook Medical Australia, LabPulse, and DrBicuspid.